WebMD, QualityHealth.com merger terminated

Share this article:

A merger between WebMD and Marketing Technology Solutions (MTS) – the parent of QualityHealth.com – has been terminated.

The $50 million merger, announced in mid-September, had been expected to be finalized by Oct. 15. Instead, WebMD has “acquired a minority preferred interest in MTS,” the statement said. Financial terms were not disclosed. A spokesperson for WebMD declined to comment on the details of the failed merger.

WebMD also entered into an advertising services agreement with QualityHealth.com, allowing WebMD to represent a portion of QualityHealth.com's media inventory. Conversely, QualityHealth.com will have limited access to certain parts of WebMD's inventory, according to the spokesperson. QualityHealth.com was not immediately available for comment.

Following a merger with Revolution Health, Waterfront Media's Everyday Health Network topped WebMD in terms of unique visitors for October, according to comScore data. WebMD had previously led the category for nearly 10 years. QualityHealth.com ranked eighth in unique visitors for October, at 7.3 million. Had the WebMD, QualtyHealth.com merger gone through, WebMD would have been in a position to rival Everyday Health's unique visitor count, and possibly exceed it.

The WebMD Network includes WebMD Health, Medscape, MedicineNet, eMedicine, eMedicine Health, RxList and theHeart.org.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.